| Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... The Lancet 381 (9860), 29-39, 2013 | 1049 | 2013 |
| Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema G Cotter, E Metzkor, E Kaluski, Z Faigenberg, R Miller, A Simovitz, ... The Lancet 351 (9100), 389-393, 1998 | 779 | 1998 |
| Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry R Fincke, JS Hochman, AM Lowe, V Menon, JN Slater, JG Webb, ... Journal of the American College of Cardiology 44 (2), 340-348, 2004 | 701 | 2004 |
| The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the sub-Saharan Africa survey of heart failure A Damasceno, BM Mayosi, M Sani, OS Ogah, C Mondo, D Ojji, A Dzudie, ... Archives of internal medicine 172 (18), 1386-1394, 2012 | 600 | 2012 |
| Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure BM Massie, CM O'Connor, M Metra, P Ponikowski, JR Teerlink, G Cotter, ... New England Journal of Medicine 363 (15), 1419-1428, 2010 | 597 | 2010 |
| Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function M Metra, B Davison, L Bettari, H Sun, C Edwards, V Lazzarini, ... Circulation: Heart Failure 5 (1), 54-62, 2012 | 524 | 2012 |
| Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes M Metra, G Cotter, BA Davison, GM Felker, G Filippatos, BH Greenberg, ... Journal of the American College of Cardiology 61 (2), 196-206, 2013 | 518 | 2013 |
| Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study JR Teerlink, M Metra, GM Felker, P Ponikowski, AA Voors, BD Weatherley, ... The Lancet 373 (9673), 1429-1439, 2009 | 517 | 2009 |
| Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance M Metra, S Nodari, G Parrinello, T Bordonali, S Bugatti, R Danesi, ... European journal of heart failure 10 (2), 188-195, 2008 | 508 | 2008 |
| Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial A Mebazaa, B Davison, O Chioncel, A Cohen-Solal, R Diaz, G Filippatos, ... The Lancet 400 (10367), 1938-1952, 2022 | 463 | 2022 |
| Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials JJV McMurray, JR Teerlink, G Cotter, RC Bourge, JGF Cleland, ... Jama 298 (17), 2009-2019, 2007 | 406 | 2007 |
| Fluid overload in acute heart failure—re‐distribution and other mechanisms beyond fluid accumulation G Cotter, M Metra, O Milo‐Cotter, HC Dittrich, M Gheorghiade European journal of heart failure 10 (2), 165-169, 2008 | 365 | 2008 |
| Diuretic response in acute heart failure: clinical characteristics and prognostic significance MAE Valente, AA Voors, K Damman, DJ Van Veldhuisen, BM Massie, ... European heart journal 35 (19), 1284-1293, 2014 | 364 | 2014 |
| The role of the kidney in heart failure M Metra, G Cotter, M Gheorghiade, L Dei Cas, AA Voors European heart journal 33 (17), 2135-2142, 2012 | 355 | 2012 |
| Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials BA Davison, SA Harrison, G Cotter, N Alkhouri, A Sanyal, C Edwards, ... Journal of hepatology 73 (6), 1322-1332, 2020 | 332 | 2020 |
| High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema A Sharon, I Shpirer, E Kaluski, Y Moshkovitz, O Milovanov, R Polak, ... Journal of the American College of Cardiology 36 (3), 832-837, 2000 | 315 | 2000 |
| Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? G Cotter, E Shemesh, M Zehavi, I Dinur, A Rudnick, O Milo, Z Vered, ... American heart journal 147 (2), 293-300, 2004 | 282 | 2004 |
| Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction E Shemesh, R Yehuda, O Milo, I Dinur, A Rudnick, Z Vered, G Cotter Psychosomatic medicine 66 (4), 521-526, 2004 | 281 | 2004 |
| Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome PC Colombo, A Ganda, J Lin, D Onat, A Harxhi, JE Iyasere, N Uriel, ... Heart failure reviews 17, 177-190, 2012 | 242 | 2012 |
| Effects of serelaxin in patients with acute heart failure M Metra, JR Teerlink, G Cotter, BA Davison, GM Felker, G Filippatos, ... New England Journal of Medicine 381 (8), 716-726, 2019 | 236 | 2019 |
